HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SKB BIO-B

388.600

+4.2001.09%

Volume:774.72K

Turnover:298.86M

Market Cap:90.54B

PE:-295.47

High:397.000

Open:387.600

Low:376.400

Close:384.400

Loading ...

Overview Company News Filings

Hong Kong Stock Movement | Kelun-Biotech B (06990) Gains Over 3% as UBS Dramatically Upgrades Sac-TMT Sales Forecast

HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%

Tiger Newspress

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Conducted Annual General Meeting

SKB Biopharma Raises HK$1.94 Billion from Share Placement

MT Newswires Live

Kelun-Biotech's Novel Cldn18.2 ADC Skb315 Ind in Combination With Tagolizumab Receives Nmpa Approval for the First-Line Treatment of Gastric/Gastro-Oesophageal Junction Cancer

THOMSON REUTERS

Sichuan Kelun-Biotech Lung Cancer Combo Gets Breakthrough Tag in China; Shares Slide 3%

MT Newswires Live

Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer

THOMSON REUTERS

Sichuan Kelun-Biotech's Core Product Sacituzumab Tirumotecan and Tagitanlimab Combination Receives Breakthrough Therapy Designation for First-Line Treatment of Metastatic Non-Squamous NSCLC by China's NMPA

Sichuan Kelun-Biotech Announces Promising Phase 1/2 Study Results for TROP2 ADC Sacituzumab Tirumotecan in Advanced Solid Tumors

Sichuan Kelun-Biotech Secures First Global Approval for Sacituzumab Tirumotecan in Treating Advanced EGFR-Mutant NSCLC

Sichuan Kelun-Biotech Raises $250 Million Through Oversubscribed Share Placement to Boost R&D and Expand Product Pipeline

Kelun-Biotech Announces Approximately US$250 Million Placement

THOMSON REUTERS

BUZZ-Sichuan Kelun-Biotech falls most in 4 weeks on discounted share sale

Sichuan Kelun-Biotech Announces New Shareholder Agreement for Placing of H Shares

Sichuan Kelun-Biotech Biopharmaceutical - Placing of 5.9 Mln Placing H Shares at Placing Price HK$331.8 per Placing H Share

THOMSON REUTERS

BRIEF-Accelerated Bookbuild Offering Of H Shares In Sichuan Kelun-Biotech Biopharmaceutical, Term Sheet Shows

Price Range Set at HK$330.20 – 341.00 for H Shares Offering - Term Sheet

THOMSON REUTERS

Accelerated Bookbuild Offering of H Shares in Sichuan Kelun-Biotech Biopharmaceutical - Term Sheet

THOMSON REUTERS

Offering Size of US$200 Mln Under Issuance of H Shares - Term Sheet

THOMSON REUTERS

SKB Biopharmaceutical Gets Upfront Payment Under Drug License Contract

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/06990/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO-B","latestPrice":388.6,"timestamp":1752826115022,"preClose":384.4,"halted":0,"volume":774718,"delay":0,"floatShares":163000000,"shares":233000000,"eps":-1.315175773222007,"marketStatus":"Market Closed","change":4.2,"latestTime":"07-18 16:08:35","open":387.6,"high":397,"low":376.4,"amount":298856495,"amplitude":0.05359,"askPrice":388.6,"askSize":200,"bidPrice":388.2,"bidSize":2600,"shortable":3,"etf":0,"ttmEps":-1.315175773222007,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":7,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":384.4,"openAndCloseTimeList":[[1752802200000,1752811200000],[1752814800000,1752825600000]],"volumeRatio":1.0305252936814662,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":163000000,"roa":"-3.41%","roe":"-9.46%","lyrEps":-1.315176,"volumeRatio":1.0305252936814662,"shares":233000000,"dividePrice":0,"high":397,"amplitude":0.05359,"preClose":384.4,"low":376.4,"week52Low":142,"pbRate":"25.04","psRate":"42.86","week52High":397,"institutionHeld":0,"latestPrice":388.6,"committee":0.857143,"eps":-1.315175773222007,"divideRate":0,"volume":774718,"delay":0,"ttmEps":-1.315175773222007,"open":387.6,"prevYearClose":163.3,"prevWeekClose":340,"prevMonthClose":327.2,"prevQuarterClose":327.2,"fiveDayClose":340,"twentyDayClose":321.4,"sixtyDayClose":300},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1143103552","title":"Hong Kong Stock Movement | Kelun-Biotech B (06990) Gains Over 3% as UBS Dramatically Upgrades Sac-TMT Sales Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=1143103552","media":"Market Watcher","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143103552?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:20","pubTimestamp":1752585636,"startTime":"0","endTime":"0","summary":"Shares of Kelun-Biotech B (06990.HK) climbed beyond 3% during trading, settling at a 2.28% rise to HK$350.60 by press time. Trading volume reached HK$116 million. UBS research indicates the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1109523465","title":"HK Movers｜HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109523465","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109523465?lang=en_us&edition=fundamental","pubTime":"2025-07-03 11:00","pubTimestamp":1751511647,"startTime":"0","endTime":"0","summary":"HK Innovative Drug Concept Stocks Rose. Biostar up 15%; Akeso up 11%; SKB Bio and Innovent Bio up more than 7%; Zai Lab up 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","09926","02563","06978","06990","01801","02137","03759","09995","01672","06606","09966","09688","02268","09606","02269","02359"],"gpt_icon":0},{"id":"2544175132","title":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544175132","media":"Reuters","labels":["executive","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544175132?lang=en_us&edition=fundamental","pubTime":"2025-06-20 22:42","pubTimestamp":1750430576,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. held its Annual General Meeting on June 20, 2025. During the meeting, several proposals were considered. The financial budget report for the year 2025 was approved. The report of the Board of Directors for the year 2024 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief on June 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL7M79yS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU1979443071.USD","BK0239","LU2148510915.USD","002422","BK1161","LU0196878994.USD","LU1934453819.USD","BK0060","06990","LU1064130708.USD"],"gpt_icon":0},{"id":"2542977835","title":"SKB Biopharma Raises HK$1.94 Billion from Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2542977835","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542977835?lang=en_us&edition=fundamental","pubTime":"2025-06-12 17:53","pubTimestamp":1749721997,"startTime":"0","endTime":"0","summary":"Drug company Sichuan Kelun-Biotech Biopharmaceutical  completed the placing of 5,918,000 shares to at least six investors at HK$331.8 apiece to raise net proceeds of a little over HK$1.94 billion, a Thursday Hong Kong bourse filing said.Proceeds will be used for the R&D, trials, registration, manufacturing, and commercialization of products; external collaborations; product pipeline portfolio expansion; and replenishment of working capital among other uses.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2542156585","title":"Kelun-Biotech's Novel Cldn18.2 ADC Skb315 Ind in Combination With Tagolizumab Receives Nmpa Approval for the First-Line Treatment of Gastric/Gastro-Oesophageal Junction Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542156585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542156585?lang=en_us&edition=fundamental","pubTime":"2025-06-12 11:50","pubTimestamp":1749700216,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nTUA6XWQLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2542711379","title":"Sichuan Kelun-Biotech Lung Cancer Combo Gets Breakthrough Tag in China; Shares Slide 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542711379","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542711379?lang=en_us&edition=fundamental","pubTime":"2025-06-11 13:07","pubTimestamp":1749618436,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  said its sacituzumab tirumotecan  in combination with tagitanlimab has received a breakthrough therapy designation in China for lung cancer, according to a Wednesday Hong Kong bourse filing.The designation, granted by China's National Medical Products Administration , covers first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer in patients without actionable genomic alterations.Kelun-Biotech said this marks the fifth breakthrough tag for sac-TMT granted by the NMPA.Sac-TMT is already approved in China for multiple indications and is being developed globally with Germany's Merck, which is leading 14 Phase 3 trials outside Greater China, the filing said.Shares of the biopharmaceutical firm were down about 3% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2542731013","title":"Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2542731013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542731013?lang=en_us&edition=fundamental","pubTime":"2025-06-11 11:17","pubTimestamp":1749611862,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nTUABB1PJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2542325795","title":"Sichuan Kelun-Biotech's Core Product Sacituzumab Tirumotecan and Tagitanlimab Combination Receives Breakthrough Therapy Designation for First-Line Treatment of Metastatic Non-Squamous NSCLC by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2542325795","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542325795?lang=en_us&edition=fundamental","pubTime":"2025-06-11 07:41","pubTimestamp":1749598882,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech's Core Product Sacituzumab Tirumotecan and Tagitanlimab Combination Receives Breakthrough Therapy Designation for First-Line Treatment of Metastatic Non-Squamous NSCLC by China's NMPA. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced that its core product, the TROP2-directed antibody-drug conjugate  sacituzumab tirumotecan , in combination with the PD-L1 monoclonal antibody  tagitanlimab, has been granted Breakthrough Therapy Designation by the National Medical Products Administration in China. This designation is specifically for the first-line treatment of locally advanced, metastatic non-squamous non-small cell lung cancer  without actionable genomic alterations. This development marks a significant milestone for the company as it continues to advance its clinical research program, which includes multiple ongoing studies in collaboration with global partners.Disclaimer: This news brief was created by Public Technologies  using generative artifici","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL5fJZVs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","06990","BK0239","LU1064131003.USD","002422","LU0196878994.USD","BK1161","LU1979443071.USD","LU2148510915.USD","BK0060","LU1934453819.USD"],"gpt_icon":0},{"id":"2542466553","title":"Sichuan Kelun-Biotech Announces Promising Phase 1/2 Study Results for TROP2 ADC Sacituzumab Tirumotecan in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2542466553","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542466553?lang=en_us&edition=fundamental","pubTime":"2025-06-10 23:49","pubTimestamp":1749570564,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Announces Promising Phase 1/2 Study Results for TROP2 ADC Sacituzumab Tirumotecan in Advanced Solid Tumors. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via PR Newswire  on June 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL1LNprl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU1934453819.USD","LU1064131003.USD","LU1979443071.USD","LU2148510915.USD","BK0060","LU1064130708.USD","BK0239","LU0196878994.USD","002422"],"gpt_icon":0},{"id":"2541897790","title":"Sichuan Kelun-Biotech Secures First Global Approval for Sacituzumab Tirumotecan in Treating Advanced EGFR-Mutant NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2541897790","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541897790?lang=en_us&edition=fundamental","pubTime":"2025-06-07 11:04","pubTimestamp":1749265493,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a leading biopharmaceutical company, has announced the approval of sacituzumab tirumotecan  by the National Medical Products Administration  for the treatment of adult patients with epidermal growth factor receptor  mutant-positive locally advanced or metastatic non-squamous non-small cell lung cancer . This approval follows the progression on EGFR-tyrosine kinase inhibitor therapy and platinum-based chemotherapy. The approval, granted in March 2025, marks the first global sanctioning of a TROP2 antibody-drug conjugate for a lung cancer indication. The decision was based on encouraging data from the OptiTROP-Lung03 study, demonstrating significant survival benefits and a manageable safety profile of sac-TMT, which could potentially establish it as a new standard of care for this patient population.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250607:nNDL9vRJ2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","LU1064131003.USD","LU1934453819.USD","LU1064130708.USD","LU1979443071.USD","06990","BK0060","LU2148510915.USD","002422","BK0239","BK1161"],"gpt_icon":0},{"id":"2541886163","title":"Sichuan Kelun-Biotech Raises $250 Million Through Oversubscribed Share Placement to Boost R&D and Expand Product Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2541886163","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541886163?lang=en_us&edition=fundamental","pubTime":"2025-06-06 10:53","pubTimestamp":1749178430,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced a successful placement of 5,918,000 H shares, raising approximately US$250 million. The shares were issued at HK$331.8 each and represented about 2.54% of the company's expanded share capital. The offering attracted strong interest from investors, being multiple times oversubscribed, with participation from global long-only funds, sovereign wealth funds, and healthcare specialist funds. This placement, the largest in the Hong Kong biopharma sector over the past year, will support the company's pipeline strategy and accelerate global clinical development, aiming to deliver innovative cancer treatments. The funds will be used for research and development, clinical trials, and enhancing internal and external technological capabilities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL2DZr2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","LU1979443071.USD","BK0060","BK1161","LU1934453819.USD","LU1064130708.USD","BK0239","002422","06990","LU0196878994.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"2541944886","title":"Kelun-Biotech Announces Approximately US$250 Million Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2541944886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541944886?lang=en_us&edition=fundamental","pubTime":"2025-06-06 10:53","pubTimestamp":1749178417,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nTUA81CT2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2541012954","title":"BUZZ-Sichuan Kelun-Biotech falls most in 4 weeks on discounted share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2541012954","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541012954?lang=en_us&edition=fundamental","pubTime":"2025-06-05 11:39","pubTimestamp":1749094790,"startTime":"0","endTime":"0","summary":"BUZZ-Sichuan Kelun-Biotech falls most in 4 weeks on discounted share sale ** Shares of Sichuan Kelun-Biotech Biopharmaceutical 6990.HK fall 6.4% to HK$336, on course for the biggest one-day drop since May 7** Stock  on track to snap two straight sessions of gains** The oncology-focused drug developer plans sale of 5.92 mln new shares, or 2.5% of the enlarged share capital, in share placement raising HK$1.96 bln  for R&D, products commercialization and expanding product pipeline portfolio** The new shares will be issued at HK$331.8 apiece, or  7.6% discount to Wednesday's close of HK$359 each ** Hang Seng Biotech Index .HSHKBIO slips 0.7%, while Hang Seng Index .HSI climbs 0.7%** YTD, stock up 107.6%    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL2N3S8034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","LU2148510915.USD","LU1064130708.USD","BK0239","002422","LU0196878994.USD","BK0060","06990","BK1161","LU1064131003.USD","LU1934453819.USD"],"gpt_icon":0},{"id":"2541097258","title":"Sichuan Kelun-Biotech Announces New Shareholder Agreement for Placing of H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2541097258","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541097258?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:54","pubTimestamp":1749081261,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced a new shareholder agreement involving the placement of new H shares under a general mandate. The agreement, which was entered into on June 5, 2025, involves Goldman Sachs and Citigroup as the overall coordinators and placing agents. This placement is part of a strategic move to raise capital, with the new shares to be listed on the Hong Kong Stock Exchange under stock code 6990. The company has clarified that there are no intentions to register these securities under the U.S. Securities Act or conduct a public offering in the United States. Additionally, proposed amendments to the articles of association have been announced.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL8J7yJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","BK4566","BK1161","IE0002270589.USD","IE00B19Z3B42.SGD","LU1267930227.SGD","06990","LU2360032135.SGD","IE0034235188.USD","BK4552","LU1868837300.USD","LU2237443549.SGD","BK0239","LU1201861249.SGD","IE0004086264.USD","BK4550","LU2237443978.SGD","LU2471134523.USD","LU1868836914.USD","LU1979443071.USD","LU1868836757.USD","LU2237443895.HKD","LU0106831901.USD","LU2471134796.USD","LU2456880835.USD","002422","LU0048573561.USD","LU0061475181.USD","LU1791807156.HKD","LU0170899867.USD","LU0098860793.USD","LU0320765646.SGD","BK4585","LU0251131958.USD","LU0742534661.SGD","BK4534","LU1894683264.USD","BK4559","LU2125154778.USD","LU2148510915.USD","LU1894683348.USD","LU2750360641.GBP","LU0130517989.USD","LU1868837136.USD","LU2471134952.CNY","BK0060","LU0196878994.USD","LU0648001328.SGD","LU0251142724.SGD","BK4588"],"gpt_icon":0},{"id":"2541475097","title":"Sichuan Kelun-Biotech Biopharmaceutical - Placing of 5.9 Mln Placing H Shares at Placing Price HK$331.8 per Placing H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2541475097","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541475097?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:51","pubTimestamp":1749081096,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S710H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2540057513","title":"BRIEF-Accelerated Bookbuild Offering Of H Shares In Sichuan Kelun-Biotech Biopharmaceutical, Term Sheet Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2540057513","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540057513?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:28","pubTimestamp":1749032889,"startTime":"0","endTime":"0","summary":"BRIEF-Accelerated Bookbuild Offering Of H Shares In Sichuan Kelun-Biotech Biopharmaceutical, Term Sheet ShowsJune 4  - ACCELERATED BOOKBUILD OFFERING OF H SHARES IN SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL - TERM SHEETOFFERING SIZE OF US$200 MILLION UNDER ISSUANCE OF H SHARES - TERM SHEETPRICE RANGE SET AT HK$330.20 – 341.00 FOR H SHARES OFFERING - TERM SHEETFurther company coverage: 6990.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S7073:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2540897057","title":"Price Range Set at HK$330.20 – 341.00 for H Shares Offering - Term Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2540897057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540897057?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:26","pubTimestamp":1749032760,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S7073:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2540057833","title":"Accelerated Bookbuild Offering of H Shares in Sichuan Kelun-Biotech Biopharmaceutical - Term Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2540057833","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540057833?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:26","pubTimestamp":1749032760,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S7073:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2540005789","title":"Offering Size of US$200 Mln Under Issuance of H Shares - Term Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2540005789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540005789?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:26","pubTimestamp":1749032760,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S7073:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2537133891","title":"SKB Biopharmaceutical Gets Upfront Payment Under Drug License Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2537133891","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537133891?lang=en_us&edition=fundamental","pubTime":"2025-05-23 19:00","pubTimestamp":1747998001,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  received an upfront payment from Windward Bio under a license agreement for an anti-thymic stromal lymphopoietin monoclonal antibody , a Friday Hong Kong bourse filing said.The payment includes cash received in February and equity interest in the parent company of Windward Bio, which was settled in May.The biopharmaceutical firm and HBM  in January granted Switzerland-based Windward Bio an exclusive license for the research, development, manufacturing, and commercialization of the drug across the globe, except in Greater China and several Southeast and West Asian countries.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990","02142","BK1583","LU0196878994.USD","BK1161","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post Market","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3158,"buy":0.6316,"hold":0.0526,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6316,"analysts":19,"updateTime":1750262400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-07-18","current":-304.526119,"percent":0,"low":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"high":-21.029201,"avg":-117.180804,"sd":78.759118,"marketCap":88812112519},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519}],"updateTime":1752903360424}}}